Avacta Group (LON:AVCT) Trading 7.5% Higher – What’s Next?

Avacta Group Plc (LON:AVCT) shares traded up 7.5% during mid-day trading on Tuesday . The stock traded as high as GBX 62 and last traded at GBX 60.75. 789,680 shares changed hands during trading, a decline of 49% from the average session volume of 1,556,788 shares. The stock had previously closed at GBX 56.50.

Avacta Group Stock Performance

The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53. The company’s 50-day moving average is GBX 57.26 and its two-hundred day moving average is GBX 62.29. The stock has a market capitalization of £275.71 million, a P/E ratio of -3.59 and a beta of 1.12.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).